ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: CML is a hematopoietic stem cell malignancy characterized by a reciprocal translocation between chromosomes 9 and 22 [t(9;22)(q34;q11.2)], which results in the formation of the Philadelphia (Ph) chromosome and the BCR::ABL1 fusion gene (1).